men types claimed acceptable for these analytes. We assayed samples from 105 normal, healthy fasted volunteers, ages 19 to 57 years, 38 men and 67 women. Samples were collected each morning of the study period by one of two experienced medical technologists.
For each analyte, we tested four specimen types on the Vision system in singlet: capillary whole blood (CB; collected in lithium heparin capillary tubes and unseparated); venipuncture whole blood (VB; imseparated blood collected with sodium fluoride for glucose, or with lithium heparin for other analytes); venipuncture plasma (VP; separated from blood collected with lithium heparin); and venipuncture serum [VS; separated in an "ssr' tube (Becton Dickinson)].
Capillary whole blood was tested within 20 mm of collection. Venous serum and plasma were separated immediately after collection and all venous blood specimens were tested in order of collection, all testing being completed in 8-10 h.
For each analyte, population means for each specimen type, and normal reference intervals calculated on VS specimens by a non-parametric method (Am J Clin Pathol 1972; 57:643-658) , were as follows:
VP, x VS Ret. mt. (Am J Clin Pathol 1942; i2:559) and to the use of lithium heparin (for CB and VP) vs sodium fluoride (for VB) in the Vision hexokinase method, with sodium fluoride producing slightly higher sample blanks due to minimal hemolysis. Sodium fluoride, not the anticoagulant of choice for Vision assay of glucose, was used here to minimize glucose loss in a large number of specimens collected over a short time. Significant differences for alkaline phosphatase represent the slight depression in enzyme activity seen in capillary blood when compared to venous blood (Clin Chem 1977; 23:1705-10) .
These statistically significant differences were judged not to be clinically significant.
We conclude that the Vision system is capable of producing (a) clinically comparable results from analyses of a variety of blood specimen types, and (b) clinically accepted normal reference intervals for the six analytes for a heterogeneous population in this area. We assayed in a short period to ensure that specimens were fresh at time of testing, while we required continuous use of the Vision system for assay of 400 tests a day for five consecutive days. The system performed very well under these circumstances, 
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also with the antibody to the heavy chain responsible, to distinguish intact immunoglobulin from free light chains. Figure 1 shows a typical The rapid "one-step" homogeneous immunoassay for amphetamine (EM"-stir;
Syva Corp., Palo Alto, CA) is designed to detect commonly abused amphetamines in urine. Certain amphetamine-like compounds such as ephedrine, phenylpropanolamine, diethylpropion (1 ), and labetalol (2) also produce positive results in the assay. Some of them-those that have a hydroxy group attached to thecarbon atom of the isopropylaniine side chain-can be distinguished from "true" amphetamines, i.e., d,l-amphetamine, d-amphetamine, and methamphetamine, with the EMIT amphetamine confirmation kit (3) . We describe the case of a teenage girl whose urine was strongly positive for amphetamine, both in the EMIT-st,r amphetamine assay and in the EMIT amphetamine confirmation testing, although no amphetamine or amphetamine-like compound had been ingested.
The etiology of a choreiform movement disorder in this 13-year-old aboriginal girl could not be established, and a drug screen was ordered. No current medications or antidotal treatment was mentioned. Toxicological screening ofa 24-h urine collection with the EMIT-5t, amphetamine assay suggested the presence of an "amphetamine" (&t = + 208). Re-testing of the same urine specimen with the EMIT amphetamine confirmation kit, again produced a strongly positive result (&t = + 173). Mass spectrometry, however, showed the presence of benzathine and excluded other basic drugs. Subsequent inquiries revealed that the patient had been treated for several days with benzathine penicillin V suspension (LPV benzathine, 500 mg q.i.d.). Both the EMITSt/FM amphetamine assay and the EMIT amphetamine confirmatory test were positive when the LPV suspension (250 mg/5 mL) was diluted 1000-fold with water. In contrast, neither urine specimens collected from patients treated with penicillin V tablets (potassium salt) nor an aqueous solution of one of these tablets (250 mgI5 mL) was positive when subjected to the EMIT-St,r amphetamine assay. Benzathine penicillin V, a bactericidal antibiotic, can be administered intramuscularly or, as in the above case, orally as a suspension. The benzathine (N,N'-dibenzylethylenediamine) component of the formulation is not derived from f3-phenylisopropylamine and is thus not structurally similar to amphetamines.
It is not listed as a cross reactant in the package information sheet (1) . Despite this, urine from a patient given benzathine penicillin V suspension cross reacted in both the EMrv-st, amphetamine assay and the EMIT amphetamine confIrmation testing. The case underlines the need to confirm positive toxicology screen results by different methodologies and emphasizes the importance of the clinician recognizing and reporting medical therapy when requesting drug screens. 
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